Maher A, Bassiouny A, Moawad M K, Hendawy D S
J Laryngol Otol. 1982 Mar;96(3):205-13. doi: 10.1017/s0022215100092446.
One hundred-and eight-six fungi were isolated from one hundred-and-eighty cases clinically diagnosed as otomycosis. They comprise 59 species of 26 genera of moulds, and 2 genera of yeasts. This large variety of mould isolates provided ample material for in vitro experiments, to evaluate the anti-fungal activity of six antimycotic substances found in the preparations currently used for the treatment of otomycosis. The antifungal activity of clotrimazole and tolnaftate in vitro was evident. For over 94 per cent of the 59 fungus species tested, the MIC was less than 0.1 micrograms/ml, and for 6 per cent it was between 0.4 and 1 microgram/ml. Concerning the other 4 antimycotic substances (iodochlorhydroxyquin, fluonilid, natamycine and polymyxin B sulphate) the MIC ranged from greater than 100 micrograms/ml to 1 microgram/ml for the majority of tested fungi. The clinical observations were mostly in accordance with these findings.
从180例临床诊断为耳霉菌病的患者中分离出186株真菌。它们包括26属59种霉菌和2属酵母菌。如此多样的霉菌分离株为体外实验提供了充足的材料,以评估目前用于治疗耳霉菌病的制剂中发现的六种抗真菌物质的抗真菌活性。克霉唑和托萘酯的体外抗真菌活性明显。在所测试的59种真菌中,超过94%的MIC小于0.1微克/毫升,6%的MIC在0.4至1微克/毫升之间。关于其他4种抗真菌物质(氯碘羟喹、氟尼辛、游霉素和硫酸多粘菌素B),大多数测试真菌的MIC范围从大于100微克/毫升到1微克/毫升不等。临床观察结果大多与这些发现一致。